Cyclopamine and jervine induce COX-2 overexpression in human erythroleukemia cells but only cyclopamine has a pro-apoptoticeffect

Experimental Cell Research

Volumn 319, Issue 7, 2013, Pages 1043-1053

  Ghezali, Lamia ^a   Leger, David Yannick ^a   Limami, Youness ^a   Cook Moreau, Jeanne ^b   Beneytout, Jean Louis ^a   Liagre, Bertrand ^a  

^a UNIVERSITÉ DE LIMOGES   (France)

^b UNIVERSITÉ DE LIMOGES   (France)

Author keywords

Apoptosis; Cyclooxygenase 2; Cyclopamine; Erythroleukemia; Jervine

Indexed keywords

ALKALOID DERIVATIVE; CYCLOOXYGENASE 2; CYCLOPAMINE; DIOSGENIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JERVINE; PHYTOSTEROL; PROTEIN KINASE C; TOMATIDINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME MECHANISM; ERYTHROLEUKEMIA; ERYTHROLEUKEMIA CELL; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

EID: 84874968453     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.01.014     Document Type: Article

References (48)

1. Banerji V., Frumm S.M., Ross K.N., Li L.S., Schinzel A.C., Hahn C.K., Kakoza R.M., Chow K.T., Ross L., Alexe G., Tolliday N., Inguilizian H., Galinsky I., Stone R.M., DeAngelo D.J., Roti G., Aster J.C., Hahn W.C., Kung A.L., Stegmaier K. The intersection of genetic and chemical genomic screens identifies GSK-3alpha as a target in human acute myeloid leukemia. J. Clin. Invest. 2012, 122:935-947.
2. Davey F.R., Abraham N., Brunetto V.L., MacCallum J.M., Nelson D.A., Ball E.D., Griffin J.D., Baer M.R., Wurster-Hill D., Mayer R.J., Schiffer C.A., Bloomfield C.D. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study. Am. J. Hematol. 1995, 49:29-38.
3. Santos F.P., Bueso-Ramos C.E., Ravandi F. Acute erythroleukemia: diagnosis and management. Expert Rev. Hematol. 2010, 3:705-718.
4. Cailleteau C., Micallef L., Lepage C., Cardot P.J., Beneytout J.L., Liagre B., Battu S. Investigating the relationship between cell cycle stage and diosgenin-induced megakaryocytic differentiation of HEL cells using sedimentation field-flow fractionation. Anal. Bioanal. Chem. 2010, 398:1273-1283.
5. Leger D.Y., Liagre B., Beneytout J.L. Role of MAPKs and NF-kappaB in diosgenin-induced megakaryocytic differentiation and subsequent apoptosis in HEL cells. Int. J. Oncol. 2006, 28:201-207.
6. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J. 1998, 12:1063-1073.
7. Cha Y.I., Solnica-Krezel L., DuBois R.N. Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins. Dev. Biol. 2006, 289:263-272.
8. Smith W.L., DeWitt D.L., Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 2000, 69:145-182.
9. Xie W.L., Chipman J.G., Robertson D.L., Erikson R.L., Simmons D.L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Nat. Acad. Sci. U.S.A. 1991, 88:2692-2696.
10. Cao Y., Prescott S.M. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J. Cell. Physiol. 2002, 190:279-286.
11. Nakanishi Y., Kamijo R., Takizawa K., Hatori M., Nagumo M. Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines. Eur. J. Cancer 2001, 37:1570-1578.
12. Sobolewski C., Cerella C., Dicato M., Ghibelli L., Diederich M. The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. Int. J. Cell Biol. 2010, 2010:215158.
13. Wun T., McKnight H., Tuscano J.M. Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma. Leuk. Res. 2004, 28:179-190.
14. Leger D.Y., Liagre B., Corbiere C., Cook-Moreau J., Beneytout J.L. Diosgenin induces cell cycle arrest and apoptosis in HEL cells with increase in intracellular calcium level, activation of cPLA2 and COX-2 overexpression. Int. J. Oncol. 2004, 25:555-562.
15. Keeler R.F. Cyclopamine and related steroidal alkaloid teratogens: their occurrence, structural relationship, and biologic effects. Lipids 1978, 13:708-715.
16. Desch P., Asslaber D., Kern D., Schnidar H., Mangelberger D., Alinger B., Stoecher M., Hofbauer S.W., Neureiter D., Tinhofer I., Aberger F., Hartmann T.N., Greil R. Inhibition of GLI, but not smoothened, induces apoptosis in chronic lymphocytic leukemia cells. Oncogene 2010, 29:4885-4895.
17. Moalic S., Liagre B., Labrousse F., Beneytout J.L. Enhanced apoptosis in retrovirally transfected osteosarcoma cells after exposure to sodium butyrate. Int. J. Oncol. 2000, 16:695-700.
18. Corbiere C., Liagre B., Terro F., Beneytout J.L. Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells. Cell Res. 2004, 14:188-196.
19. Liagre B., Vergne-Salle P., Corbiere C., Charissoux J.L., Beneytout J.L. Diosgenin, a plant steroid, induces apoptosis in human rheumatoid arthritis synoviocytes with cyclooxygenase-2 overexpression. Arthritis Res. Ther. 2004, 6:R373-383.
20. Smiley S.T., Reers M., Mottola-Hartshorn C., Lin M., Chen A., Smith T.W., Steele G.D., Chen L.B. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc. Nat. Acad. Sci. U.S.A. 1991, 88:3671-3675.
21. Leger D.Y., Liagre B., Beneytout J.L. Low dose leflunomide activates PI3K/Akt signalling in erythroleukemia cells and reduces apoptosis induced by anticancer agents. Apoptosis 2006, 11:1747-1760.
22. Pinon A., Limami Y., Micallef L., Cook-Moreau J., Liagre B., Delage C., Duval R.E., Simon A. A novel form of melanoma apoptosis resistance: melanogenesis up-regulation in apoptotic B16-F0 cells delays ursolic acid-triggered cell death. Exp. Cell Res. 2011, 317:1669-1676.
23. Lepage C., Leger D.Y., Bertrand J., Martin F., Beneytout J.L., Liagre B. Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells. Cancer Lett. 2010, 301:193-202.
24. Limami Y., Pinon A., Leger D.Y., Pinault E., Delage C., Beneytout J.L., Simon A., Liagre B. The P2Y2/Src/p38/COX-2 pathway is involved in the resistance to ursolic acid-induced apoptosis in colorectal and prostate cancer cells. Biochimie 2012, 94:1754-1763.
25. Green D.R., Reed J.C. Mitochondria and apoptosis. Science 1998, 281:1309-1312.
26. Xu Z., Choudhary S., Voznesensky O., Mehrotra M., Woodard M., Hansen M., Herschman H., Pilbeam C. Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis. Cancer Res. 2006, 66:6657-6664.
27. Limami Y., Pinon A., Leger D.Y., Mousseau Y., Cook-Moreau J., Beneytout J.L., Delage C., Liagre B., Simon A. HT-29 colorectal cancer cells undergoing apoptosis overexpress COX-2 to delay ursolic acid-induced cell death. Biochimie 2011, 93:749-757.
28. Lasa M., Mahtani K.R., Finch A., Brewer G., Saklatvala J., Clark A.R. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol. Cell. Biol. 2000, 20:4265-4274.
29. Ferraris C., Cooklis M., Polakowska R.R., Haake A.R. Induction of apoptosis through the PKC pathway in cultured dermal papilla fibroblasts. Exp. Cell Res. 1997, 234:37-46.
30. Simeone A.M., Nieves-Alicea R., McMurtry V.C., Colella S., Krahe R., Tari A.M. Cyclooxygenase-2 uses the protein kinase C/interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells. Int. J. Oncol. 2007, 30:785-792.
31. Tang J., Li H.L., Shen Y.H., Jin H.Z., Yan S.K., Liu R.H., Zhang W.D. Antitumor activity of extracts and compounds from the rhizomes of Veratrum dahuricum. Phytother. Res. 2008, 22:1093-1096.
32. Kawahara T., Kawaguchi-Ihara N., Okuhashi Y., Itoh M., Nara N., Tohda S. Cyclopamine and quercetin suppress the growth of leukemia and lymphoma cells. Anticancer Res. 2009, 29:4629-4632.
33. Chen X.L., Cheng Q.Y., She M.R., Wang Q., Huang X.H., Cao L.Q., Fu X.H., Chen J.S. Expression of sonic hedgehog signaling components in hepatocellular carcinoma and cyclopamine-induced apoptosis through Bcl-2 downregulation in vitro. Arch. Med. Res. 2010, 41:315-323.
34. Han M.E., Lee Y.S., Baek S.Y., Kim B.S., Kim J.B., Oh S.O. Hedgehog signaling regulates the survival of gastric cancer cells by regulating the expression of Bcl-2. Int. J. Mol. Sci. 2009, 10:3033-3043.
35. Wang K., Pan L., Che X., Cui D., Li C. Gli1 inhibition induces cell-cycle arrest and enhanced apoptosis in brain glioma cell lines. J. Neurooncol. 2010, 98:319-327.
36. Trouillas P., Corbiere C., Liagre B., Duroux J.L., Beneytout J.L. Structure-function relationship for saponin effects on cell cycle arrest and apoptosis in the human 1547 osteosarcoma cells: a molecular modelling approach of natural molecules structurally close to diosgenin. Bioorg. Med. Chem. 2005, 13:1141-1149.
37. Aggarwal B.B. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004, 6:203-208.
38. Giri D.K., Aggarwal B.B. Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. J. Biol. Chem. 1998, 273:14008-14014.
39. Cohen P. Protein kinases-the major drug targets of the twenty-first century?. Nat. Rev. Drug Discovery 2002, 1:309-315.
40. Ridley S.H., Dean J.L., Sarsfield S.J., Brook M., Clark A.R., Saklatvala J. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett. 1998, 439:75-80.
41. Bachelor M.A., Silvers A.L., Bowden G.T. The role of p38 in UVA-induced cyclooxygenase-2 expression in the human keratinocyte cell line, HaCaT. Oncogene 2002, 21:7092-7099.
42. Dean J.L., Brook M., Clark A.R., Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 1999, 274:264-269.
43. Sun Y., Tang X.M., Half E., Kuo M.T., Sinicrope F.A. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res. 2002, 62:6323-6328.
44. Liu W.S., Heckman C.A. The sevenfold way of PKC regulation. Cell. Signal. 1998, 10:529-542.
45. Parker P.J., Murray-Rust J. PKC at a glance. J. Cell Sci. 2004, 117:131-132.
46. Duggan S.V., Lindstrom T., Iglesias T., Bennett P.R., Mann G.E., Bartlett S.R. Role of atypical protein kinase C isozymes and NF-kappaB in IL-1beta-induced expression of cyclooxygenase-2 in human myometrial smooth muscle cells. J. Cell Physiol. 2007, 210:637-643.
47. Inoue H., Yokoyama C., Hara S., Tone Y., Tanabe T. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J. Biol. Chem. 1995, 270:24965-24971.
48. Molina-Holgado E., Ortiz S., Molina-Holgado F., Guaza C. Induction of COX-2 and PGE(2) biosynthesis by IL-1beta is mediated by PKC and mitogen-activated protein kinases in murine astrocytes. Br. J. Pharmacol. 2000, 131:152-159.